Istvan Edes
Istvan Edes
Professor of Cardiology, Institute of Cardiology, University of Debrecen, Hungary
Email verificata su med.unideb.hu
Titolo
Citata da
Citata da
Anno
Edoxaban versus warfarin in patients with atrial fibrillation
RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ...
New England Journal of Medicine 369 (22), 2093-2104, 2013
44172013
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and …
WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ...
European heart journal 28 (20), 2539-2550, 2007
34032007
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre …
European Trial on Reduction of Cardiac Events with Perindopril in Stable ...
The Lancet 362 (9386), 782-788, 2003
27612003
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
10612008
Cardiomyocyte stiffness in diastolic heart failure
A Borbély, J Van Der Velden, Z Papp, JGF Bronzwaer, I Edes, ...
Circulation 111 (6), 774-781, 2005
5732005
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain
A Tóth, J Boczán, N Kedei, E Lizanecz, Z Bagi, Z Papp, I Édes, L Csiba, ...
Molecular Brain Research 135 (1-2), 162-168, 2005
4492005
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
3812018
EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events …
KM Fox
Lancet 362, 782-788, 2003
364*2003
Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium
A Borbély, I Falcao-Pires, L van Heerebeek, N Hamdani, I Edes, C Gavina, ...
Circulation research 104 (6), 780-786, 2009
3582009
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
E Kiss, G Jakab, EG Kranias, I Edes
Circulation research 75 (2), 245-251, 1994
3301994
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data
M Gyöngyösi, W Wojakowski, P Lemarchand, K Lunde, M Tendera, ...
Circulation research 116 (8), 1346-1360, 2015
2992015
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
Z Papp, I Édes, S Fruhwald, SG De Hert, M Salmenperä, H Leppikangas, ...
International journal of cardiology 159 (2), 82-87, 2012
2912012
Effects of Levosimendan, a Cardiotonic Agent Targeted to Troponin C, on Cardiac Function and on Phosphorylation and Ca2+ Sensitivity of Cardiac Myofibrils and …
I Edes, E Kiss, Y Kitada, FM Powers, JG Papp, EG Kranias, RJ Solaro
Circulation research 77 (1), 107-113, 1995
2741995
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo …
HA Ghofrani, G Simonneau, AM D'Armini, P Fedullo, LS Howard, X Jaďs, ...
The Lancet Respiratory Medicine 5 (10), 785-794, 2017
1802017
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
J Bartunek, A Terzic, BA Davison, GS Filippatos, S Radovanovic, ...
European heart journal 38 (9), 648-660, 2017
1652017
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan
Z Papp, K Csapó, P Pollesello, H Haikala, I Édes
Cardiovascular drug reviews 23 (1), 71-98, 2005
1612005
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
M Gyöngyösi, I Lang, M Dettke, G Beran, S Graf, H Sochor, N Nyolczas, ...
Nature Clinical Practice Cardiovascular Medicine 6 (1), 70-81, 2009
1592009
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig
S Szilágyi, P Pollesello, J Levijoki, P Kaheinen, H Haikala, I Édes, Z Papp
European journal of pharmacology 486 (1), 67-74, 2004
1372004
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations
MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ...
International journal of cardiology 191, 256-264, 2015
1332015
Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus
T Szerafin, N Erdei, T Fülöp, ET Pasztor, I Édes, A Koller, Z Bagi
Circulation research 99 (5), e12-317, 2006
1322006
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20